- Report
- November 2025
- 194 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- June 2025
- 209 Pages
Global
From €2231EUR$2,500USD£1,967GBP
- Report
- December 2024
- 150 Pages
Global
From €5309EUR$5,950USD£4,681GBP
- Report
- September 2025
- 250 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- November 2025
- 576 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- November 2025
- 182 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- August 2025
- 146 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- January 2025
- 129 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- July 2025
- 150 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP
- Report
- August 2025
- 123 Pages
North America
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3452EUR$3,869USD£3,044GBP
- Report
- November 2023
- 124 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- January 2023
- 124 Pages
Global
From €2008EUR$2,250USD£1,770GBP
- Report
- November 2022
- 113 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- October 2020
- 120 Pages
Global
From €2231EUR$2,500USD£1,967GBP
- Report
- October 2024
- 200 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$4,202USD£3,194GBP

The Mono Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Mono Vaccines are a type of vaccine that protect against a single pathogen, such as measles, mumps, rubella, or varicella. These vaccines are typically administered to children and are often combined with other vaccines to form a combination vaccine. Mono Vaccines are typically administered in a single dose, and are often given in combination with other vaccines to form a combination vaccine.
The Mono Vaccine market is highly competitive, with a number of companies offering products. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Other companies in the market include AstraZeneca, CSL, Emergent BioSolutions, and Johnson & Johnson. Show Less Read more